nonalcoholic steatohepatitis

Monocyte phenotypic liquid biopsy for NASH and liver fibrosis diagnosis: a new kid on the block
Yasmina Chouik, Massimo Levrero

Gut Jan 2024, 73 (1) 10-11; DOI: 10.1136/gutjnl-2022-328189
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
Alessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, Monica Cucco, Giulio V Dalla Riva, Edoardo G Giannini, Fabio Piscaglia, Gianludovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Giuseppe Cabibbo, Fabio Marra, Andrea Mega, Filomena Morisco, Antonio Gasbarrini, Francesco Giuseppe Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Filippo Oliveri, Filippo Pelizzaro, Rafael Ramirez Morales, Umberto Cillo, Franco Trevisani, Luca Miele, Giulio Marchesini, Fabio Farinati

Gut Jan 2023, 72 (1) 141-152; DOI: 10.1136/gutjnl-2021-324915
MAFLD, HCC and the dilemma of (changing) terminology in liver diseases
Ruben Hernaez, Markus Peck-Radosavljevic

Gut Jan 2023, 72 (1) 9-11; DOI: 10.1136/gutjnl-2022-326992
Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD
Thomas Marjot, Jeremy W Tomlinson, Leanne Hodson, David W Ray

Gut Aug 2023, 72 (8) 1607-1619; DOI: 10.1136/gutjnl-2023-329998
Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19
Yunyu Zhao, Yee Hui Yeo, Jamil Samaan, Fan Lv, Xinyuan He, Ning Gao, Justin Park, Ju Dong Yang, Walid Ayoub, Michelle C Odden, Fanpu Ji, Mindie H Nguyen

Gut Aug 2023, 72 (8) 1628-1630; DOI: 10.1136/gutjnl-2022-328188
Diabetes is the strongest risk factor of hepatic fibrosis in lean patients with non-alcoholic fatty liver disease
Huiyul Park, Eileen L Yoon, Seon Cho, Dae Won Jun, Eun-Hee Nah

Gut May 2022, 71 (5) 1035-1036; DOI: 10.1136/gutjnl-2021-325102
Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease
Nobuharu Tamaki, Nagambika Munaganuru, Jinho Jung, Aed Qas Yonan, Rohan R Loomba, Richele Bettencourt, Veeral Ajmera, Mark A Valasek, Cynthia Behling, Claude B Sirlin, Rohit Loomba

Gut May 2022, 71 (5) 983-990; DOI: 10.1136/gutjnl-2021-324264
Time to consider a holistic approach to the treatment of non-alcoholic fatty liver disease in obese young people?
Christopher D Byrne, Giovanni Targher

Gut Jul 2023, 72 (7) 1238-1239; DOI: 10.1136/gutjnl-2022-328316
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis
Federico Ravaioli, Elton Dajti, Alessandro Mantovani, Philip Noel Newsome, Giovanni Targher, Antonio Colecchia

Gut Jul 2023, 72 (7) 1399-1409; DOI: 10.1136/gutjnl-2022-328689
Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals
Alessandro Mantovani, Alessandro Csermely, Herbert Tilg, Christopher D Byrne, Giovanni Targher

Gut Jul 2023, 72 (7) 1433-1436; DOI: 10.1136/gutjnl-2022-328224

Main menu

nonalcoholic steatohepatitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

nonalcoholic steatohepatitis

Pages